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BACKGROUND. African-American (AA) women have lower survival rates from
cervical cancer compared with white women. The objective of this study was to
examine the influence of socioeconomic status (SES) and other variables on
racial disparities in overall survival among women with invasive cervical cancer.
METHODS. One thousand thirty-six women (705 white women and 331 AA
women) who were diagnosed with primary invasive cancer of the cervix between
1988 and 1992 were identified through the Metropolitan Detroit Cancer Surveil-
lance System (MDCSS), a registry in the Surveillance, Epidemiology, and End
Results (SEER) database. Pathology, treatment, and survival data were obtained
through SEER. SES was categorized by using occupation, poverty, and educational
status at the census tract level. Cox proportional hazards models were used to
compare overall survival between AA women and white women adjusting for
sociodemographics, clinical presentation, and treatment.
RESULTS. AA women were more likely to present at an older age (P < .001), with
later stage disease (P < .001), and with squamous histology (P 5 .01), and they
were more likely to reside in a census tract categorized as Working Poor (WP)
(P < .001). After multivariate adjustment, race no longer had a significant impact
on survival. Women who resided in a WP census tract had a higher risk of death
than women from a Professional census tract (P 5 .05). There was a significant
interaction between disease stage and time with the effect of stage on survival
attenuated after 6 years.
CONCLUSIONS. In this study, factors that affected access to medical care appeared
to have a more important influence than race on the long-term survival of
women with invasive cervical cancer. Cancer 2008;112:1264–71.  2008
American Cancer Society.
KEYWORDS: cervical cancer, survival, race, socioeconomic status, Surveillance,
Epidemiology, and End Results.
C ancer of the cervix is the third most common malignancy of thefemale reproductive system.1 The American Cancer Society esti-
mates that 11,150 women will be diagnosed with and 3670 women
will die from cervical cancer in 2007.2 Data from the Surveillance,
Epidemiology, and End Results (SEER) Program have indicated that,
whereas the 5-five year relative survival rates for cervical cancer
have increased from 1975 to 2002 for all women (from 69.1% to
73.5%), survival rates remain lower for African-American (AA)
women compared with white women.3 During the period from 1996
to 2002, the relative survival rates were 75% and 67% for white
women and AA women, respectively.1
Racial differences in cervical cancer have been attributed to
several factors, including stage at presentation,4–13 treatment differ-
ences,4,5,8,10,14,15 comorbid conditions,14 and SES.6,7,14,16–23 Unlike
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information on stage and treatment, however, data-
bases used by public health researchers generally do
not include information on individual SES. SES has
been described in the cervical cancer literature using
various combinations of measures, including poverty
level, occupation, educational level, and insurance
status. In addition, SES was defined in several studies
using the United States Census at the neighborhood
(census tract level) or zip code level as a proxy for
individual SES.7,14,16,18,20–22 In this regard, Krieger
et al. designed the Public Health Disparities Geocod-
ing Project to determine which specific measures of
socioeconomic position (education, income, occupa-
tion, poverty level) and which geographic level would
be most useful for health surveillance and
research.24–26 In their study on mortality rates and
cancer incidence using SEER data, they observed
that data based on census tract (average population,
4000) or on census block group (average population,
1000) performed similarly for all outcomes, including
external validity, robustness, completeness, and user
friendliness. However, the use of data at the United
States Postal Service zip code level (average popula-
tion 30,000) failed in some tests of external validity.24
In the current study, we used data from the
Metropolitan Detroit Cancer Surveillance System
(MDCSS) to determine whether SES had an effect on
the observed difference in survival among AA women
and white women with cervical cancer. On the basis
of methods reported by Krieger et al.,27 using census
tract level data, we defined an SES variable by using
information on education, occupation, and poverty
as a proxy for individual SES status. This model
offers a more inclusive method of defining SES than
has been used in other studies that investigated the




The study population consisted of women diagnosed
with a first primary invasive cancer of the cervix
uteri (International Classification of Diseases for
Oncology codes C53.0–53.1 and 53.8–53.9).28 Women
were identified from 1988 to 1992 from the MDCSS,
which allowed for a 10-year follow-up through 2002.
The SEER Program of the National Cancer Institute
reports cancer incidence and survival data on
approximately 26% of the United States population.
It was initiated in 1973, with Detroit as 1 of 7 found-
ing members, and now consists of 17 registries
throughout the United States.29 From January 1, 1988
to December 31, 1992, there were 1073 incident cases
of female invasive cervical cancer diagnosed in the
Detroit metropolitan area: Seven hundred twenty-
seven cases (62%) were classified in the SEER registry
as white, and 346 cases (29.5%) were classified as AA.
Racial designations of other (n 5 13), including
American Indian, Chinese, Filipino, Korean, Asian In-
dian, and Laotian, or unknown (n 5 17), were not
included because of the lack of sufficient numbers.
In total, 20 women (2%) were excluded from the
analysis, because they had tumors with nonspecific
histology (neoplasm malignant; tumor cells malig-
nant; or carcinoma undifferentiated, not otherwise
specified [NOS]). Another 17 women (1.7%) were
excluded if they had a rare histology (carcinoma,
anaplastic, NOS; basal cell carcinoma, NOS; neuro-
endocrine carcinoma; leiomyosarcoma; mullerian
mixed tumor; carcinosarcoma; and mesonephroma,
malignant). After these exclusions, the final sample
size was 1036 women.
Definition of Variables
Tumor characteristics
Tumor stage was defined according to the Interna-
tional Federation of Gynecology and Obstetrics
(FIGO) staging system as stage I, IIA, IIB, III, IV, or
unknown. Women with stage IIB cervical cancer are
considered to have locally advanced disease and,
unlike women with stage IIA disease, are treated with
primary chemotherapy and radiation.30 Tumor grade
was classified as well differentiated, moderately dif-
ferentiated, poorly differentiated, undifferentiated, or
unknown. Lymph node involvement was classified as
negative, positive, or unknown. Histology was catego-
rized as squamous cell carcinoma (SCC), adenocarci-
noma, or adenosquamous carcinoma. Tumor size
was divided into 4 categories: 7 mm, from 8 mm to
4 cm, >4 cm, or unknown.
Demographic characteristics
Marital status at diagnosis was defined as married,
unknown, or other (single, separated, divorced, or
widowed). Race was classified as AA or white. Age at
diagnosis was categorized as <50 years or 50 years.
Treatment
Surgery and radiation therapy were categorized into
a variable that was labeled ‘‘first course of cancer-
directed treatment.’’ Surgery was categorized as no
cancer-directed surgery, local surgery only, simple
hysterectomy, radical hysterectomy, or unknown.
Local surgery included local surgical excision, exci-
sional biopsy, trachelectomy, amputation of cervix or
cervical stump, laser surgery with pathology speci-
men, or conization. Surgical therapy for preinvasive
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disease, fertility preservation (cryosurgery, laser sur-
gery, and dilation and curettage), staging evaluation
for debulking (pelvic exenteration, surgery of regional
and/or distant sites only), and information on sur-
gery that was nonspecific (hysterectomy, NOS or sur-
gery, NOS) was excluded. The data on surgery were
categorized further as either no surgery or surgery of
any type. Radiation therapy was classified as none or
refused, external beam radiation therapy alone, radi-
oactive implants or isotopes with or without external
beam radiation therapy, or radiation, NOS or planned
radiotherapy. Only 2 women refused radiation ther-
apy and were included with the patients who did not
receive any radiation. Like the surgery variable,
radiation therapy was categorized further into either
no radiation therapy received or radiation therapy of
any type. We used information on surgery and radia-
tion therapy to create a first course of cancer-direc-
ted treatment variable that consisted of the following
5 categories: neither surgery nor radiation, surgery
only, radiation therapy only, surgery and radiation
therapy, and unknown. Chemotherapy use was clas-
sified as chemotherapy that was either administered
or planned, either not administered or refused, or
unknown.
SES
A census tract number was obtained from the
MDCSS for each woman in the study based on her
address at the time of diagnosis. The 1990 United
States Census of Population and Housing Summary
Tape File 3A was used to obtain socioeconomic data
for census tract.31 The variables that were used to
create SES categories included occupation, poverty
status, and educational attainment. Occupation was
included because it could serve as a proxy for insur-
ance status, in that most health insurance is ob-
tained through an employer. The 1990 United States
Census defined 13 occupational categories; 5 for
‘Professional’ occupations and 8 for ‘Working Class’
occupations. We defined SES variables corresponding
to census tracts based on the definitions published
by Krieger et al. for census block groups.27 ‘Working
Class’ block groups were defined as those in which
66.67% of the population in that census block
reported a ‘working class’ occupation, such as a la-
borer. ‘Professional’ groups were those in which
33.33% of employed individuals were in executive
or supervisory roles. ‘Poor’ groups were those in
which 20% of the population lived below the pov-
erty level, which was $12,674 for a family of 4 in
1990. ‘Educated’ groups were those in which 75%
of individuals aged 25 years had completed at least
a high school education.
Women were assigned to 1 of 8 SES groups,
including 1) Working, Poor, Undereducated; 2) Work-
ing, Poor, Educated; 3) Working, Nonpoor, Underedu-
cated; 4) Working, Nonpoor, Educated; 5) Professional,
Poor, Undereducated; 6) Professional, Poor, Edu-
cated; 7) Professional, Nonpoor, Undereducated; and
8) Professional, Nonpoor, Educated. Because there
were insufficient numbers for a meaningful analysis
in some of the SES groups, the groups were collapsed
into 4 mutually exclusive categories as follows: 1)
Working, Poor (WP); 2) Working, Nonpoor, Undere-
ducated (WNP-UE); 3) Working, Nonpoor, Educated
(WNP-E); and 4) Professional (P).
Statistical Analysis
Chi-square tests were used to compare the demo-
graphic characteristics, clinical characteristics, and
treatment modalities in AA women and white women.
P values <.05 were considered statistically signifi-
cant. The primary endpoint was overall survival,
which was defined as the time from diagnosis to
death from any cause. Univariate (unadjusted) analy-
sis of overall survival was performed using Kaplan-
Meier estimates and the log-rank test. Cox pro-
portional hazards regression was used to assess the
effect of race on overall survival after adjusting for
age at diagnosis (aged <50 years, aged 50 years),
marital status (married, other), SES (WP, WNP-UE,
WNP-E, P), stage (I, II, III, IV), chemotherapy (none/
refused, chemotherapy/planned), first-course treat-
ment (neither surgery or radiation, surgery only,
radiation only, both surgery and radiation), and his-
tology (adenocarcinoma, squamous, adenosqua-
mous). Tumor grade, size, and lymph node status
were not included in the multivariable model be-
cause of a lack of statistical significance in the uni-
variate analysis and the large proportion of women
with missing information. Tumor size information
was accounted for in the FIGO staging classification.
RESULTS
There were 705 white women and 331 AA women
who were included in the study. The mean age at
diagnosis was 51.1 years (standard deviation [SD], 17
years), and the mean age was 52.8 years (SD, 16.7
years) for AA women and 50.4 years (SD, 17.1 years)
for white women. The median follow-up was 185
months. Demographic characteristics, clinical char-
acteristics and treatment modalities of the study
population stratified by race are shown in Table 1.
There were statistically significant differences in all
of the characteristics examined except for tumor
grade and lymph node status. AA women were more
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likely to be older at diagnosis (54.1% diagnosed at
age 50 years vs 46.5% of white women; P 5 .02)
and were less likely to be married, (26.6% vs 49.9%
of white women; P < .001).With regard to SES, AA
women were more likely to reside in a census tract
categorized as WP (73.1% vs 15.2%), whereas white
women were more likely to reside in a census tract
designated as P (33% vs 13.9%; P < .001). AA women
also were less likely to present at diagnosis with ear-
lier stage disease (48.9% presented with stage I dis-
ease vs 59.6% of white women; P < .001) and were
more likely to have large tumors at the time of diag-
nosis (13.9% had tumors that measured >4 cm com-
pared with 6% of white women; P 5 .003). AA women
were more likely to have tumors that were of SCC
histology (87.9% vs 80.6%; P 5 .01). With regard to
treatment, AA women were more likely to have
received or planned to receive chemotherapy (26.3%
vs 15.9%; P < .001). Treatment with surgery or radia-
tion also differed between the races (P < .001). White
women were more likely to undergo surgery only
(40.1% vs 27.6%), whereas AA women were more
likely to receive radiation only (39.4% vs 30.8%).
Slightly more AA women had neither surgery nor
radiation (10.9% vs 8.5%).
Survival Analysis
The median survival of women who were diagnosed
with invasive cervical cancer in the Detroit Metro-
politan area between 1988 and 1992 was 127 months.
The unadjusted analyses (data not shown) demon-
strated that AA women had a significantly increased
risk of death (hazard ratio [HR], 1.49; 95% confidence
interval [CI], 1.26–1.76) compared with white women.
However, when the multivariable model (Table 2)
was adjusted simultaneously for age, marital status,
SES, histology, stage, and treatment, race no longer
had a significant impact on survival (HR, 1.12; 95%
CI, 0.89–1.42). Older women as expected, had an
increased risk of death compared with younger
women (HR, 2.28; 95% CI, 1.84–2.83). Being married
appeared to have a modest negative influence on
survival (HR, 1.23; 95% CI, 1.01–1.50). Women from
the WP census tract had a modestly higher, but not
statistically significant, greater risk of death com-
pared with women from the P census tract (HR, 1.30;
95% CI, 1.00–1.69), and there were no significant dif-
ferences observed for any of the other census tract
groupings (WNP-UE or WNP-E) compared with the P
group. Nonsquamous histology (adenocarcinoma or
adenosquamous carcinoma) was a significant predic-
tor of worse outcome (adenocarcinoma: HR, 1.89;
95% CI, 1.41–2.54; adenosquamous carcinoma: HR,
2.34; 95% CI, 1.62–3.37). Women who either under-
TABLE 1
Demographic and Clinical Characteristics of Women With Invasive
Cervical Cancer From the 1988 to 1992 Detroit Surveillance,






P*% No. % No.
Age at diagnosis, y .02
<50 53.5 377 45.9 152
50 46.5 328 54.1 179
Marital status at diagnosis <.001
Married 49.9 352 26.6 88
Other 43.7 308 65.9 218
Unknown 6.4 45 7.6 25
SESy <.001
Professional 33 233 13.9 46
Working, nonpoor, educated 22.8 161 3.3 11
Working, nonpoor, undereducated 28.1 198 9.4 31
Working poor 15.2 107 73.1 242
Unknown 0.9 6 0.3 1
Stage (FIGO) <.001
I 59.6 420 48.9 162
IIA 5.7 40 2.1 7
IIB 12.5 88 17.5 58
III 8.8 62 12.7 42
IV 7.1 50 8.5 28
Unknown 6.4 45 10.3 34
Grade .76
1 5.4 38 4.2 14
2 15.7 111 14.2 47
3 18.4 130 19.9 66
4 2.7 19 2.7 9
Unknown 57.7 407 58.9 195
Lymph node status .51
Negative 55.7 393 44.1 146
Positive 10.5 74 9.7 32
Unknown 33.8 238 46.2 153
Tumor size .003
7 mm 5.7 40 7.3 24
8 mm to 4 cm 12.2 86 9.1 30
>4 cm 6 42 13.9 46
Unknown 76.2 537 69.8 231
Histology .01
Squamous 80.6 568 87.9 291
Adenocarcinoma 14 99 7.9 26
Adenosquamous 5.4 38 4.2 14
Chemotherapy <.001
None/refused 84 592 73.7 244
Chemotherapy/planned 15.9 112 26.3 87
Missing 0.1 1 0 0
Surgery and radiation <.001
No surgery or radiation 8.5 60 10.9 36
Surgery only 40.1 283 27.6 91
Radiation only 30.8 217 39.4 130
Both 16.3 115 18.2 60
Unknown 4.3 30 3.9 13
AA indicates African American; SES, socioeconomic status; FIGO, International Federation of Gyne-
cology and Obstetrics.
* Comparisons were performed by using chi-square tests. ‘‘Unknown’’ categories were not included
in the computation of the chi-square statistics.
y SES was categorized by using occupation, poverty, and educational status at the census tract level.
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went surgery alone, or received radiation therapy
alone, or both underwent surgery and received radio-
therapy were more likely to have better survival than
women who did not undergo any surgery or receive
any radiation, and whether or not women received
chemotherapy had no significant impact on survival.
The effect of disease stage on survival appeared to
decay over time when women who had stage II, III,
or IV disease were compared with women who had
stage I disease. After 6 years, the effect of disease
stage on overall survival was no longer statistically
significant (data not shown).
DISCUSSION
Our univariate analysis demonstrated racial differ-
ences in survival, with AA women experiencing worse
overall survival compared with white women; how-
ever, after simultaneously adjusting for multiple
potential confounders, including a proxy measure for
SES, race no longer had a significant impact on cer-
vical cancer survival. Several previous studies have
evaluated race specifically as a predictor of survival
for women with cervical cancer.4,5,7,8,32–38 Four of 10
studies demonstrated that AA women had worse sur-
vival compared with white women despite adjustment
for several potential confounder variables,5,8,32,36
whereas 6 of 10 studies showed no racial differences
in survival after multivariate adjustment.4,33–35,37,38
Thoms et al.34 reported no survival differences be-
tween AA women and white women after adjustment
for stage, age and histology. However in their study,
127 women (80%) were AA, and the small number of
white women may have limited the power of the
study to evaluate survival differences by race. Grigsby
et al.33 evaluated 922 women (207 AA women and 715
white women) at the Mallinckrodt Institute of Radiol-
ogy with either stage II or stage III disease who
received radiation therapy and observed no racial dif-
ference in cancer-specific survival. However, the 5-
year overall survival rate for patients who were diag-
nosed with stage II disease was significantly less for
AA women compared with white women (51% vs
60%, respectively; P 5 .02). This difference in survival
was attributed to other noncancer-related factors.33
In our study, factors that were associated with
poor survival included advanced stage at presenta-
tion, lack of appropriate surgery, being married, non-
squamous histology, and increasing age. Several
reports have demonstrated that AA women have
worse survival secondary to presenting at a later
stage of disease.4–13 According to our data, white
women were more likely to present with stage I dis-
ease than AA women. Eggleston et al.7 studied 7237
women with cervical cancer in the Texas Cancer Reg-
istry from 1995 to 2001. Disease stage in that study
was categorized as early stage (IA1, IA2, or IB) and
late stage (II, III, IV). Consistent with our results, AA
women were more likely to be diagnosed with late-
stage disease (47.3%) than non-Hispanic white
women (37.1%). A cervical cancer-specific survival
analysis demonstrated that women who were diag-
nosed at a later stage were 6.2 times more likely to
die within 80 months than women who were diag-
nosed at an early stage and that AA women were 1.3
times more likely to die than white women.
Treatment disparities between AA women and
white women also have been evaluated in several
studies.4,5,8,10,14,15 In our study, a slightly greater per-
centage of AA women compared with white women
did not receive either surgery or radiation. Our popu-
TABLE 2
Multivariate Predictors of Overall Survival Using Cox Proportional
Hazards Modeling in Women From the 1988 to 1992 Detroit
Surveillance, Epidemiology, and End Results Database (N 5 862)
Variable/Comparison*
Time since
diagnosis, y HR 95% CI P
Race
Black vs white Any 1.12 0.89–1.42 .33
Age. y
50 vs <50 Any 2.28 1.84–2.83 <.001
Marital status at diagnosis
Married vs other Any 1.23 1.01–1.50 .04
SESy
WP vs P Any 1.30 1.00–1.69 .05
WNP-UE vs P Any 1.12 0.85–1.47 .43
WNP-E vs P Any 0.99 0.72–1.35 .93
Histology
Adenocarcinoma vs squamous Any 1.89 1.41–2.54 <.001
Adenosquamous vs squamous Any 2.34 1.62–3.37 <.001
Stage
II vs I 2 1.96 1.45–2.66 <.001
4 1.65 1.26–2.17 <.001
6 1.39 1.05–1.85 .02
III vs I 2 3.50 2.44–5.01 <.001
4 2.69 1.90–3.80 <.001
6 2.07 1.40–3.06 <.001
IV vs I 2 9.04 6.10–13.40 <.001
4 5.85 3.46–9.89 <.001
6 3.79 1.78–8.03 <.001
Chemotherapy
Received vs none Any 1.10 0.87–1.40 .43
Surgery and radiation
Surgery only vs neither Any 0.15 0.10–0.23 <.001
Radiation only vs neither Any 0.50 0.33–0.76 <.001
Both vs neither Any 0.38 0.25–0.58 <.001
HR indicates hazard ratio; CI, confidence interval; SES, socioeconomic status; WP, working poor;
P, professional; WNP-UE, working, nonpoor, undereducated; WNP-E, working, nonpoor, educated.
* The model included all of the variables listed in the table.
y SES was categorized by using occupation, poverty, and educational status at the census tract level.
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lation of AA women was older than the white popu-
lation. Consistent with our results, many studies
have demonstrated that increasing age is associated
with worsening survival among women with cervical
cancer.8,16,17,20,21,38–40 Older women may use screen-
ing less often and may present at a later stage; thus,
they may have lower survival rates. Other explana-
tions include the possibility that older patients are
more likely to refuse treatment or to have comorbid
conditions that preclude standard cancer treat-
ment.41 Mundt et al.14 demonstrated that AA women
with locally advanced disease were less likely to
receive intracavitary radiation therapy (ICRT) than
white women (13% vs 4%; P 5 .07). This was attribu-
ted either to technical problems in placing the ICRT
or to the greater prevalence of other comorbid health
conditions in the AA women. In both the study by
Mundt et al. and our study, receipt of radiation ther-
apy was associated with better survival compared
with no therapy.
Studies on histology and survival have demon-
strated worsening survival for women who have
nonsquamous histology compared with women who
have squamous histology,16,23,34,38,42 consistent with
our results. It has been postulated that this is
because nonsquamous cancers are not detected as
easily on Papanicolaou smears. It is noteworthy that,
in the Cancer Prevention and Control Surveillance
Program study, of 17,119 women evaluated, there
were no statistically significant differences in 5-year
relative survival rates between women with adeno-
carcinoma and women with SCC. However, when
comparing survival rates for adenosquamous carci-
noma with the rates for SCC, the 5-year relative sur-
vival was 54.9% for adenosquamous and 67.2% for
SCC (P 5 .05).38
The literature examining marital status and cer-
vical cancer survival is scant. In the report by Mur-
phy et al.,19 >1000 women from the South Thames
Cancer Registry were classified as single, married,
widowed, or divorced. That study indicated that, af-
ter adjustment for age, there were no significant
differences in survival according to marital status.
Our study indicated that being married tended to
have a modest negative influence on survival,
although we have no reasonable explanation for
that finding.
The strengths of our study include the large
population size, the long period of follow-up, and the
use of SES on a census tract level. In articles that exam-
ined cervical cancer survival and SES,6,7,14,16–23 6 of
11 studies indicated that women with lower SES had
poorer survival.6,7,17,20–22 Eggleston et al.7 reported
on 5467 women with cervical cancer. In their study,
an SES variable was defined by using measures of
employment, income, education, and poverty at the
zip code level. After adjusting for stage, lower SES
was associated with poorer survival (HR, 1.9; 95% CI,
1.6–2.3; P < .001). In their report, AA race still was
associated with poorer survival after adjusting for
SES (HR, 1.3; 95% CI, 1.1–1.5). In the study by Green-
wald et al.,18 race was associated independently with
survival, but SES was not. In that study, SES was
based on the percentage of high school graduates
among individuals aged 25 years in each zip code
area. Race continued to predict mortality after
adjusting for SES, although using education alone as
a proxy for SES, especially in a large geographic area,
may have not been an adequate method for estimat-
ing SES. In fact, SES has not been defined consis-
tently in the literature, which may explain in part the
variability in the reported results.
However, there are inherent problems in using
the SEER registry for data collection. All data are col-
lected from medical records and are only as com-
plete or accurate as the original medical record. An
evaluation of racial classification in the Detroit SEER
registry revealed that AAs were 4 times more likely to
be misclassified with regard to their race than whites,
although the agreement between self-reported race
and registry race was 99.7%.43 Another potential pro-
blem is that we used overall survival as an outcome
rather than cancer-specific survival, because the
cause of death variable derived from death certificate
information is prone to misclassification.44,45 In addi-
tion, differences in overall survival between AA
women and white women may be related to a
higher prevalence of comorbid conditions among AA
women, data that are not collected in the SEER
database. Some studies have evaluated the impact of
comorbid conditions on cervical cancer survival,
including the level of pretreatment hemoglobin dur-
ing cancer-directed therapy to explain racial differ-
ences in cervical cancer survival14,15,46; however,
further work needs to be done to evaluate the impact
of other comorbid conditions on survival. There
also are potential biologic differences in tumor
aggressiveness and response to treatment between
AA women and white women that should be eva-
luated further, because they may explain survival
differences.
The current study adds to the existing literature
on racial differences in cervical cancer using a popu-
lation-based source of data. In addition, it offers a
more refined method for studying racial differences
in survival in the context of SES. Our results demon-
strate that poor survival in AA women is explained at
least in part by low SES as well as by other variables
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that have a potential impact on access to care. It is
important for policy makers to improve access to
early screening, early detection, and treatment
opportunities to reduce and eventually, not only
eliminating discrepancies in stage at presentation
but also resulting in more equitable survival for all
women who are diagnosed with cervical cancer.
Furthermore, clinicians must remind women beyond
their childbearing years of the importance of conti-
nuing to screen for cervical cancer.
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